US Tech 100

18,244.80

0.27%

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
USOTC
Neonmind Biosciences Inc (PK) (NMDBF)
Neonmind Biosciences Inc (PK) (NMDBF) News

NMDBF

Neonmind Biosciences (PK) (NMDBF)

Neonmind Biosciences Inc (PK)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:NMDBF

1

Date	Time	Source	Headline	Symbol	Company
09/28/2021	5:45AM	InvestorsHub NewsWire	NeonMind Advances Strategy for Specialty Clinic Launch	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
09/22/2021	5:30AM	InvestorsHub NewsWire	NeonMind Strengthens its Specialty Clinics Advisory Board with Appointment of Mood Disorders and Ketamine Expert Dr. Gustavo Vazquez, MD, PhD	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
09/16/2021	10:39AM	InvestorsHub NewsWire	NeonMind Appoints Ketamine and Neurostimulation Expert Dr. Roumen Milev, MD, PhD to Specialty Clinic Advisory Board	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
09/08/2021	5:31AM	InvestorsHub NewsWire	NeonMind to Present at H.C. Wainwright 23rd Annual Global Investment Conference	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
07/28/2021	6:03AM	InvestorsHub NewsWire	Dr. Sagar Parikh, MD Appointed to NeonMind Specialty Clinics Advisory Board	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
06/29/2021	7:50AM	InvestorsHub NewsWire	NeonMind Announces Launch of Functional Mushroom Coffees as Dietary Supplements in the US	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
06/10/2021	6:57AM	InvestorsHub NewsWire	NeonMind Announces Vitasave Will Carry NeonMind Functional Mushroom Products	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
05/28/2021	7:24AM	InvestorsHub NewsWire	NeonMind to Commence Trading on the OTCQB Venture Market	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
04/06/2021	7:10AM	InvestorsHub NewsWire	NeonMind Developing Music Playlist for Psychedelic Therapy Sessions	USOTC:NMDBF	Neonmind Biosciences Inc (PK)
03/09/2021	7:00AM	InvestorsHub NewsWire	NeonMind Engages Pharma Executive Philippe Martin to Advance its Psilocybin Drug Candidates for Obesity	USOTC:NMDBF	Neonmind Biosciences Inc (PK)